Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Complete response after “neoadjuvant” pertuzumab + trastuzumab + docetaxel chemotherapy in Her2-positive breast cancer
1Oncology Unit Gard Cancer Institute, Nîmes (France)
*Corresponding Author(s): F. Lai-Tiong E-mail: florencelt@hotmail.fr
It is well demonstrated that Her-2 positive breast cancer patients have more aggressive disease, with a poor prognosis. The author report the case of a 50-year-old Caucasian woman, diagnosed with a seven-centimeter right breast cancer. Biospy core revealed a Her-2 positive, positive for hormonal receptors, ki67 at 70%, breast invasive ductal carcinoma, associated with right axillary adenomegalies. Positron emission tomography scan showed diffuse metastatic adenomegalies upper and under the diaphragm and a 55×55 mm lesion in the right breast. The patient began chemotherapy with docetaxel+pertuzumab+trastuzumab regimen. After three courses, all the positron emission tomography scans did not show any pathological hypermetabolism and the primitive lesion was measured at 16×18 mm. It was decided to perform a right mastectomy. The patient will then follow maintenance with pertuzumab and trastuzumab, in combination with hormonotherapy.
Her2 breast cancer; Pertuzumab; Metastatic breast cancer; Her2-targeted therapies.
F. Lai-Tiong. Complete response after “neoadjuvant” pertuzumab + trastuzumab + docetaxel chemotherapy in Her2-positive breast cancer. European Journal of Gynaecological Oncology. 2018. 39(5);836-837.
[1] Ross J.S., Slodkowska E.A., Symmans W.F., Pusztai L., Ravdin P.M., Hortobagyi G.N.: “The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine”. Oncologist, 2009, 14, 320.
[2] Chia S.K., Speers C.H., D’yachkova Y., Kang A., Malfair-Taylor S., Barnett J., et al.: “The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer”. Cancer, 2007, 110, 973.
[3] Slamon D.J., Leyland-Jones B., Shak S., Fuchs H., Paton V., Bajamonde A., et al.: “Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2”. N. Engl. J. Med., 2001, 344, 783
[4] Rapiti E., Verkooijen H.M., Vlastos G., Fioretta G., Neyroud-Caspar I., Sappino A.P., et al: “Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis”. J. Clin. Oncol., 2006, 24, 2743,
[5] Khan S.A., Stewart A.K., Morrow M.: “Does aggressive local therapy improve survival in metastatic breast cancer?” Surgery, 2002, 132, 620.
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.
Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.
JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.
Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.
BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Top